LAB — Standard BioTools Inc

Ownership history in JOHNSON & JOHNSON  ·  8 quarters on record

This page tracks every 13F SEC filing in which JOHNSON & JOHNSON reported a position in Standard BioTools Inc (LAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.14% (2024 Q4)
Avg. % of fund
0.1%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 311,967 — 0% 0.07% $399K $1.28
2025 Q3 UNCHANGED 311,967 — 0% 0.08% $406K $1.30
2025 Q2 UNCHANGED 311,967 — 0% 0.11% $371K $1.20
2025 Q1 UNCHANGED 311,967 — 0% 0.10% $337K $1.08
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LAB price (monthly, adj. close)

Other funds also holding LAB

As of 2025 Q4 — sorted by position size

Casdin Capital, LLC 3Y 7Y 7.06% MAK CAPITAL ONE LLC 3Y 7Y 2.72% Nan Fung Group Holdings Ltd 3Y 2.16% Hollow Brook Wealth Management LLC 3Y 7Y 1.84% Tikvah Management LLC 3Y 7Y 1.21% Long Focus Capital Management, LLC 3Y 0.43% QVIDTVM Management LLC 3Y 0.33% VIKING GLOBAL INVESTORS LP 3Y 7Y 0.2% Intellectus Partners, LLC 3Y 7Y 0.1% Amova Asset Management Americas, Inc. 3Y 7Y 0.06%
← Back to JOHNSON & JOHNSON Holdings